Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$412M |
| 2 |
Advanced Micro Devices
AMD
|
+$294M |
| 3 |
Apple
AAPL
|
+$244M |
| 4 |
Qualcomm
QCOM
|
+$207M |
| 5 |
Pinduoduo
PDD
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$510M |
| 2 |
Uber
UBER
|
+$419M |
| 3 |
Chevron
CVX
|
+$286M |
| 4 |
Meta Platforms (Facebook)
META
|
+$255M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.64% |
| 2 | Healthcare | 18.28% |
| 3 | Consumer Discretionary | 13.73% |
| 4 | Industrials | 8.66% |
| 5 | Financials | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DFSV
1901
Dimensional US Small Cap Value ETF
DFSV
$8.19B
| $1.95M | ﹤0.01% |
67,900
+27,700
| +69% | +$804K |
|
|
SMLR
1902
DELISTED
Semler Scientific
SMLR
| $1.95M | ﹤0.01% |
56,800
-24,600
| -30% | -$709K |
|
1903
Acco Brands
ACCO
$389M
| $1.94M | ﹤0.01% |
413,500
+91,600
| +28% | +$457K |
|
1904
Benchmark Electronics
BHE
$2.87B
| $1.94M | ﹤0.01% |
49,100
-8,300
| -14% | -$305K |
|
1905
Scholastic
SCHL
$767M
| $1.94M | ﹤0.01% |
+54,577
| New | +$1.95M |
|
1906
Saga Communications
SGA
$57M
| $1.93M | ﹤0.01% |
122,744
+6,800
| +6% | +$136K |
|
1907
Omega Flex
OFLX
$297M
| $1.93M | ﹤0.01% |
37,695
+11,515
| +44% | +$735K |
|
|
ZUO
1908
DELISTED
Zuora, Inc.
ZUO
| $1.93M | ﹤0.01% |
194,400
-29,800
| -13% | -$287K |
|
1909
Domo
DOMO
$174M
| $1.93M | ﹤0.01% |
249,700
-69,200
| -22% | -$517K |
|
1910
CVB Financial
CVBF
$3.94B
| $1.93M | ﹤0.01% |
111,694
+65,800
| +143% | +$1.1M |
|
1911
Neurogene
NGNE
$656M
| $1.92M | ﹤0.01% |
52,807
-5,900
| -10% | -$208K |
|
1912
Pulmonx
LUNG
$68.8M
| $1.91M | ﹤0.01% |
301,410
+34,800
| +13% | +$268K |
|
1913
Titan Machinery
TITN
$396M
| $1.9M | ﹤0.01% |
119,800
-6,700
| -5% | -$140K |
|
1914
Arcosa
ACA
$7.13B
| $1.9M | ﹤0.01% |
+22,800
| New | +$1.9M |
|
1915
Sibanye-Stillwater
SBSW
$6.26B
| $1.9M | ﹤0.01% |
436,935
+242,735
| +125% | +$1.2M |
|
1916
iShares Core S&P Mid-Cap ETF
IJH
$122B
| $1.9M | ﹤0.01% |
+32,400
| New | +$1.9M |
|
1917
-1x Short VIX Futures ETF
SVIX
$174M
| $1.88M | ﹤0.01% |
39,500
+31,200
| +376% | +$1.35M |
|
1918
Mirion Technologies
MIR
$3.73B
| $1.87M | ﹤0.01% |
174,000
-128,500
| -42% | -$1.37M |
|
1919
Precigen
PGEN
$2.24B
| $1.87M | ﹤0.01% |
1,182,690
+130,500
| +12% | +$189K |
|
1920
Vivid Seats
SEAT
$84.6M
| $1.86M | ﹤0.01% |
16,211
+10,491
| +183% | +$1.14M |
|
1921
Seacoast Banking Corp of Florida
SBCF
$3.36B
| $1.86M | ﹤0.01% |
78,605
+35,700
| +83% | +$833K |
|
1922
Huntsman Corp
HUN
$1.71B
| $1.85M | ﹤0.01% |
81,400
-415,700
| -84% | -$10.1M |
|
1923
Kingstone Companies
KINS
$289M
| $1.85M | ﹤0.01% |
369,389
+19,201
| +5% | +$87.6K |
|
|
FBCG
1924
DELISTED
Fidelity Blue Chip Growth ETF
FBCG
| $1.85M | ﹤0.01% |
+43,500
| New | +$1.72M |
|
1925
Atossa Therapeutics
ATOS
$20.6M
| $1.85M | ﹤0.01% |
103,394
+10,969
| +12% | +$243K |
|
Similar funds
Renaissance Technologies's Q2 2024 Portfolio in Review
As of Q2 2024, Renaissance Technologies held 4,123 positions worth $59B, down 7.3% from $63.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $4.49B in Q2 2024, closing 675 positions and reducing 1,503 holdings. Its most notable exit was Bank of America, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Broadcom worth $472M.
- Renaissance Technologies's largest Q2 2024 buy was Broadcom: 2,941,150 shares worth $472M.
- Renaissance Technologies added most to Apple in Q2 2024, an estimated $244M increase.
- Renaissance Technologies's biggest Q2 2024 reduction was Amazon, cutting an estimated $510M.
- Renaissance Technologies fully exited Bank of America in Q2 2024, selling an estimated $142M.
- Renaissance Technologies's ten largest holdings make up 12% of its $59B portfolio in Q2 2024.
- Renaissance Technologies opened 463 new positions and closed 675 in Q2 2024.
- Renaissance Technologies's portfolio value fell 7.3% quarter-over-quarter to $59B.
Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.